AP NEWS

Global Ankylosing Spondylitis Epidemiology and Patient Flow Analysis 2018-2026 - ResearchAndMarkets.com

June 12, 2018

DUBLIN--(BUSINESS WIRE)--Jun 12, 2018--The “Global Ankylosing Spondylitis Epidemiology and Patient Flow Analysis - 2018” report has been added to ResearchAndMarkets.com’s offering.

The research provides insights into Ankylosing Spondylitis epidemiology, Ankylosing Spondylitis diagnosed patients, and Ankylosing Spondylitis treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Ankylosing Spondylitis derived from epidemiological analysis, patients diagnosed with Ankylosing Spondylitis, and patients treated with a drug therapy.

The research study helps executives estimate Ankylosing Spondylitis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Ankylosing Spondylitis prevalence, Ankylosing Spondylitis diagnosis rate, and Ankylosing Spondylitis treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

Ankylosing Spondylitis Patient Flow Ankylosing Spondylitis Prevalence Ankylosing Spondylitis Diagnosed Patients Ankylosing Spondylitis Treated Patients

Key Topics Covered

1. Ankylosing Spondylitis: Disease Definition

2. Global Ankylosing Spondylitis Patient Flow

2A. Global Ankylosing Spondylitis Prevalence

2B. Global Ankylosing Spondylitis Diagnosed Patients

2C. Global Ankylosing Spondylitis Treated Patients

3. Ankylosing Spondylitis Patient Flow in the US

3A. Ankylosing Spondylitis Prevalence in the US

3B. Ankylosing Spondylitis Diagnosed Patients in the US

3C. Ankylosing Spondylitis Treated Patients in the US

4. Ankylosing Spondylitis Patient Flow in Europe

4A. Ankylosing Spondylitis Prevalence in Europe

4B. Ankylosing Spondylitis Diagnosed Patients in Europe

4C. Ankylosing Spondylitis Treated Patients in Europe

5. Ankylosing Spondylitis Patient Flow in Germany

5A. Ankylosing Spondylitis Prevalence in Germany

5B. Ankylosing Spondylitis Diagnosed Patients in Germany

5C. Ankylosing Spondylitis Treated Patients in Germany

6. Ankylosing Spondylitis Patient Flow in France

6A. Ankylosing Spondylitis Prevalence in France

6B. Ankylosing Spondylitis Diagnosed Patients in France

6C. Ankylosing Spondylitis Treated Patients in France

7. Ankylosing Spondylitis Patient Flow in Spain

7A. Ankylosing Spondylitis Prevalence in Spain

7B. Ankylosing Spondylitis Diagnosed Patients in Spain

7C. Ankylosing Spondylitis Treated Patients in Spain

8. Ankylosing Spondylitis Patient Flow in Italy

8A. Ankylosing Spondylitis Prevalence in Italy

8B. Ankylosing Spondylitis Diagnosed Patients in Italy

8C. Ankylosing Spondylitis Treated Patients in Italy

9. Ankylosing Spondylitis Patient Flow in UK

9A. Ankylosing Spondylitis Prevalence in UK

9B. Ankylosing Spondylitis Diagnosed Patients in UK

9C. Ankylosing Spondylitis Treated Patients in UK

10. Ankylosing Spondylitis Patient Flow in Japan

10A. Ankylosing Spondylitis Prevalence in Japan

10B. Ankylosing Spondylitis Diagnosed Patients in Japan

10C. Ankylosing Spondylitis Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/ghd88q/global_ankylosing?w=4.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180612006484/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Musculoskeletal Disorders Drugs

KEYWORD: UNITED STATES EUROPE ASIA PACIFIC NORTH AMERICA JAPAN

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS PHARMACEUTICAL PROFESSIONAL SERVICES OTHER PROFESSIONAL SERVICES RESEARCH SCIENCE

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/12/2018 04:27 PM/DISC: 06/12/2018 04:27 PM

http://www.businesswire.com/news/home/20180612006484/en

AP RADIO
Update hourly